## The 27.5 MHz Cancer Disruptor: A New Weapon in the War on Cancer
Medical Disclaimer: The information in this article is for educational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
The Shocking Discovery That Could Change Cancer Treatment Forever
What if the key to fighting cancer wasn’t a new drug, but a specific frequency? For decades, the war on cancer has been fought with three main weapons: surgery, radiation, and chemotherapy. While these have saved countless lives, they are brutal, sledgehammer approaches that often cause as much damage as they cure. But what if there was a fourth weapon? A silent, invisible force that could disrupt cancer cells with surgical precision, leaving healthy cells untouched?
In 2009, a team of researchers led by Dr. Alexandre Barbault made a groundbreaking discovery that has the potential to revolutionize oncology. They found that by using a specific radio frequency—**27.12 MHz**—as a carrier wave, they could deliver a payload of cancer-specific frequencies that would disrupt the growth of tumor cells [1]. This isn’t science fiction. This is the cutting edge of frequency medicine, and it’s showing incredible promise in the fight against one of the world’s deadliest diseases.
The Science of 27.12 MHz: How It Works
The concept is both elegant and profound. The 27.12 MHz frequency, which is globally approved for medical use and has been used safely in diathermy for decades, acts as a delivery vehicle. It’s able to penetrate deep into the body without being absorbed by surface tissues. But the real magic happens with the **amplitude modulation**—the specific, low-frequency signals that are piggybacked onto the carrier wave.
Dr. Barbault’s team discovered that different types of cancer cells respond to different modulation frequencies. Using a biofeedback technique, they identified over 1,500 frequencies between 0.1 Hz and 114 kHz that were specific to different tumor types. Most remarkably, they found four “universal” frequencies that were effective against multiple cancers, including breast, liver, prostate, and pancreatic cancer:
- 1873.5 Hz
- 2221.3 Hz
- 6350.3 Hz
- 10,456.4 Hz
The prevailing theory is that these specific frequencies interfere with the mitotic spindle formation during cell division, effectively stopping cancer cells from replicating. It’s like throwing a wrench into the gears of the cancer machine, causing it to grind to a halt.
Figure 1: How 27.12 MHz carrier wave delivers tumor-specific frequencies to disrupt cancer cell division
The Clinical Evidence: A Glimmer of Hope for Advanced Cancer
The most compelling evidence for this technology comes from a 2011 phase I/II clinical trial on patients with advanced hepatocellular carcinoma (HCC), a type of liver cancer with a very poor prognosis [2]. The results were astonishing:
| Metric | Result | Significance |
|---|---|---|
| No Tumor Progression | 34.1% of patients beyond 6 months | Shows a significant slowing of the disease |
| Median Progression-Free Survival | 4.4 months | Extends the time before the cancer worsens |
| Median Overall Survival | 6.7 months | Extends the lifespan of patients with a terminal diagnosis |
While these numbers may seem modest, for patients with no other options, they represent a lifeline. The treatment was delivered non-invasively, with very low power (SAR <2 W/kg), and with no reported adverse side effects. This is a stark contrast to the debilitating side effects of chemotherapy and radiation.
How to Use This Technology Today: The PEMF Healing App & iTorus Coil
While the specific 27.12 MHz device used in the clinical trials is not commercially available, the principles of frequency medicine can be applied today using the PEMF Healing App and a powerful PEMF device like the iTorus Coil. The app contains a vast library of frequencies, including many that are relevant for cancer support, cellular health, and immune function.
By using the iTorus Coil to generate a robust PEMF field, you can deliver these healing frequencies deep into your body, creating an environment where cancer cells struggle to survive and your healthy cells can thrive. Here is a sample protocol for general cancer support:
The 12-Week Cancer Support Protocol
Phase 1: Immune Activation & Detox (Weeks 1-4)
Goal: Prepare the body for cellular targeting by boosting the immune system and clearing detoxification pathways.
Protocol:
- Immune System Stimulation 2 – Daily, 30 minutes
- Lymphatic Drainage and Detox – Daily, 20 minutes
Phase 2: Cellular Targeting (Weeks 5-8)
Goal: Directly target cancer cells and support healthy cellular function.
Protocol:
- Cancer Cells Killer 2 – Daily, 45 minutes
- Mitochondrial Energy – Daily, 20 minutes
Phase 3: Maintenance & Regeneration (Weeks 9-12+)
Goal: Continue to suppress cancer growth and promote the regeneration of healthy tissue.
Protocol:
- Fenbendazole Cellular Detox – 3x per week, 30 minutes
- Cellular communication – Rejuvenation – 3x per week, 30 minutes
The Future of Cancer Treatment
The 27.5 MHz cancer disruptor is not a cure, but it represents a monumental shift in our understanding of how to fight cancer. It’s a move away from brute force and towards a more intelligent, targeted approach that works *with* the body’s own energetic systems. As research continues, we may one day see a future where cancer is managed not with toxic chemicals, but with the precise application of healing frequencies.
This is the future of medicine. This is the power of frequency. And it’s available to you today through the PEMF Healing App.
References
[1] Mattsson, M. O., & Simkó, M. (2019). “Emerging medical applications based on non-ionizing electromagnetic fields from 0 Hz to 10 THz.” Medical Devices: Evidence and Research, 12, 347–368. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746309/
[2] Costa, F. P., et al. (2011). “Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields.” British Journal of Cancer, 105(5), 640–648. https://www.nature.com/articles/bjc2011292
[3] Barbault, A., et al. (2009). “Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach.” Journal of Experimental & Clinical Cancer Research, 28(1), 51. https://doi.org/10.1186/1756-9966-28-51